Evidence map›Paper›PMID 25695232›Full record

ArticleCell transplantation2015

Extensive Characterization of Platelet Gel Releasate From Cord Blood in Regenerative Medicine.

Valentina Parazzi, Cristiana Lavazza, Valentina Boldrin, Elisa Montelatici, Francesco Pallotti, Maurizio Marconi, Lorenza Lazzari

Abstract read
PubMed Publisher
In one paragraph

Article in Cell transplantation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Safety and efficacy of eye drops from umbilical cord blood platelet lysate to treat resistant corneal ulcer.Medical hypothesis, discovery & innovation ophthalmology journal · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Cord Blood Platelet Lysate: In Vitro Evaluation to Support the Use in Regenerative Medicine.Mediterranean journal of hematology and infectious diseases · 2019
    Article
  18. Article
  19. Article
  20. Platelet gel: a new therapeutic tool with great potential.Blood transfusion = Trasfusione del sangue · 2017
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Valentina ParazziCell Factory, Unit for Cellular Therapy and Cryobiology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
Cristiana Lavazza
Valentina Boldrin
Elisa Montelatici
Francesco Pallotti
Maurizio Marconi
Lorenza Lazzari

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Platelet gel derived from peripheral blood is widely applied in many clinical fields of surgery as biomaterial containing growth factors with high proliferative properties. In 2010, we studied and patented a platelet gel derived from cord blood. In this study, due to the crucial role of the factors released by the platelet gel, we first extended the characterization of its releasate. Using a wide proteomic array and splitting the two components of the releasate, that is, platelets and plasma, we have been able to study their growth factor content. Interestingly, we discovered high levels of hormones and molecules able to support tissue growth in the cord blood platelet gel releasate and, in addition, higher concentrations of several angiogenic factors if compared with the peripheral blood counterpart. On the contrary, the latter was much richer in inflammatory factors. The second aim of our work was to study the effects on cell culture, immunophenotype, and function of mesenchymal stem cells exposed to these two platelet gel releasates as substitute for the animal serum. Since our findings nicely show that the use of the peripheral versus the cord blood platelet gel releasate can differently influence the mesenchymal stem cell commitment, we can suggest that in addition to its peculiar angiogenic properties cord blood platelet gel releasate shows excellent proliferative properties as cell culture supplement.

Indexed as

AdultBlood PlateletsCell Culture TechniquesCell DifferentiationCell ExtractsCell ProliferationFetal BloodGene Expression ProfilingHumansInfant, NewbornIntercellular Signaling Peptides and ProteinsMaleMesenchymal Stem CellsMiddle AgedProteomeRegenerative MedicineCell ExtractsIntercellular Signaling Peptides and ProteinsProteome

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.